Cannapharmarx, Inc. financial data

Symbol
CPMD on OTC
Location
Calgary, Alberta, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.47 %
Quick Ratio 3.5 %
Debt-to-equity -153 %
Return On Equity 34.3 %
Return On Assets -64.9 %
Operating Margin -248 % +25.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 663M shares 0%
Common Stock, Shares, Outstanding 663M shares 0%
Entity Public Float 9.28M USD
Common Stock, Value, Issued 66.3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 663M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 663M shares +125%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.71M USD +405%
General and Administrative Expense 81.4K USD -37.5%
Operating Income (Loss) -4.23M USD -276%
Nonoperating Income (Expense) -542K USD -177%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.24M USD +31%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -7.32M USD -631%
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.21K USD -44%
Accounts Receivable, after Allowance for Credit Loss, Current 14.1K USD
Inventory, Net 864K USD -29.2%
Other Assets, Current 0 USD -100%
Assets, Current 1.47M USD -1.78%
Property, Plant and Equipment, Net 123K USD -19.9%
Operating Lease, Right-of-Use Asset 5.5M USD -0.13%
Assets 11.6M USD -0.55%
Accounts Payable, Current 5.61M USD -37.3%
Accrued Liabilities, Current 4.39M USD
Liabilities, Current 28.5M USD +26.6%
Liabilities 34.1M USD +20.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 174K USD +335%
Retained Earnings (Accumulated Deficit) -102M USD -0.68%
Stockholders' Equity Attributable to Parent -22.5M USD -35.8%
Liabilities and Equity 11.6M USD -0.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -601K USD -9.58%
Net Cash Provided by (Used in) Financing Activities 600K USD +7.17%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 663M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -948 USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 927 USD -86.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 0 USD -100%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.19M USD -647%
Property, Plant and Equipment, Gross 211K USD +3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure
Deferred Tax Assets, Operating Loss Carryforwards 24.6M USD +3.07%
Preferred Stock, Shares Authorized 3.2M shares
Operating Lease, Payments 261K USD +29.1%
Additional Paid in Capital 81.4M USD +1.57%
Preferred Stock, Shares Outstanding 629K shares
Depreciation, Depletion and Amortization 0 USD
Deferred Tax Assets, Net of Valuation Allowance 25M USD +3.2%
Interest Expense 2.1M USD -14.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%